Skip to main content
Top
Published in: Journal of Nephrology 2/2017

01-04-2017 | Original Article

The spectrum of renal involvement in male patients with infertility related to excretory-system abnormalities: phenotypes, genotypes, and genetic counseling

Authors: Roger Mieusset, Isabelle Fauquet, Dominique Chauveau, Laetitia Monteil, Nicolas Chassaing, Myriam Daudin, Antoine Huart, François Isus, Cathy Prouheze, Patrick Calvas, Eric Bieth, Louis Bujan, Stanislas Faguer

Published in: Journal of Nephrology | Issue 2/2017

Login to get access

Abstract

Background

While reproductive technologies are increasingly used worldwide, epidemiologic, clinical and genetic data regarding infertile men with combined genital tract and renal abnormalities remain scarce, preventing adequate genetic counseling.

Methods

In a cohort-based study, we assessed the prevalence (1995–2014) and the clinical characteristics of renal disorders in infertile males with genital tract malformation. In a subset of 34 patients, we performed a detailed phenotype analysis of renal and genital tract disorders.

Results

Among the 180 patients with congenital uni- or bilateral absence of vas deferens (CU/BAVD), 45 (25 %) had a renal malformation. We also identified 14 infertile men with combined seminal vesicle (SV) and renal malformation but no CU/BAVD. Among the 34 patients with detailed clinical description, renal disease was unknown before the assessment of the infertility in 27 (79.4 %), and 7 (20.6 %) had chronic renal failure. Four main renal phenotypes were observed: solitary kidney (47 %); autosomal-dominant polycystic kidney disease (ADPKD, 0.6 %); uni- or bilateral hypoplastic kidneys (20.6 %); and a complex renal phenotype associated with a mutation of the HNF1B gene (5.8 %). Absence of SV and azoospermia were significantly associated with the presence of a solitary kidney, while dilatation of SV and necroasthenozoospermia were suggestive of ADPKD.

Conclusion

A dominantly inherited renal disease (ADPKD or HNF1B-related nephropathy) is frequent in males with infertility and combined renal and genital tract abnormalities (26 %). A systematic renal screening should be proposed in infertile males with CU/BAVD or SV disorders.
Appendix
Available only for authorised users
Literature
1.
go back to reference Forti G, Krausz C (1998) Clinical review 100: evaluation and treatment of the infertile couple. J Clin Endocrinol Metab 83:4177–4188PubMed Forti G, Krausz C (1998) Clinical review 100: evaluation and treatment of the infertile couple. J Clin Endocrinol Metab 83:4177–4188PubMed
2.
go back to reference Mak V, Jarvi KA (1996) The genetics of male infertility. J Urol 156:1245–56; discussion 1256–7 Mak V, Jarvi KA (1996) The genetics of male infertility. J Urol 156:1245–56; discussion 1256–7
3.
go back to reference Jequier AM, Ansell ID, Bullimore NJ (1985) Congenital absence of the vasa deferentia presenting with infertility. J Androl 6:15–19PubMed Jequier AM, Ansell ID, Bullimore NJ (1985) Congenital absence of the vasa deferentia presenting with infertility. J Androl 6:15–19PubMed
4.
go back to reference Oates RD, Amos JA (1994) The genetic basis of congenital bilateral absence of the vas deferens and cystic fibrosis. J Androl 15:1–8PubMed Oates RD, Amos JA (1994) The genetic basis of congenital bilateral absence of the vas deferens and cystic fibrosis. J Androl 15:1–8PubMed
5.
go back to reference Dumur V, Gervais R, Rigot J-M et al (1990) Abnormal distribution of CF ΔF508 allele in azoospermic men with congenital aplasia of epididymis and vas deferens. Lancet 336:512CrossRefPubMed Dumur V, Gervais R, Rigot J-M et al (1990) Abnormal distribution of CF ΔF508 allele in azoospermic men with congenital aplasia of epididymis and vas deferens. Lancet 336:512CrossRefPubMed
6.
go back to reference Anguiano A, Oates RD, Amos JA et al (1992) Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis. JAMA 267:1794–1797CrossRefPubMed Anguiano A, Oates RD, Amos JA et al (1992) Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis. JAMA 267:1794–1797CrossRefPubMed
7.
go back to reference Torra R, Sarquella J, Calabia J et al (2008) Prevalence of cysts in seminal tract and abnormal semen parameters in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 3:790–793CrossRefPubMedPubMedCentral Torra R, Sarquella J, Calabia J et al (2008) Prevalence of cysts in seminal tract and abnormal semen parameters in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 3:790–793CrossRefPubMedPubMedCentral
8.
go back to reference Schlegel PN, Shin D, Goldstein M (1996) Urogenital anomalies in men with congenital absence of the vas deferens. J Urol 155:1644–1648CrossRefPubMed Schlegel PN, Shin D, Goldstein M (1996) Urogenital anomalies in men with congenital absence of the vas deferens. J Urol 155:1644–1648CrossRefPubMed
9.
go back to reference McCallum T, Milunsky J, Munarriz R et al (2001) Unilateral renal agenesis associated with congenital bilateral absence of the vas deferens: phenotypic findings and genetic considerations. Hum Reprod 16:282–288CrossRefPubMed McCallum T, Milunsky J, Munarriz R et al (2001) Unilateral renal agenesis associated with congenital bilateral absence of the vas deferens: phenotypic findings and genetic considerations. Hum Reprod 16:282–288CrossRefPubMed
10.
go back to reference Daudin M, Bieth E, Bujan L et al (2000) Congenital bilateral absence of the vas deferens: clinical characteristics, biological parameters, cystic fibrosis transmembrane conductance regulator gene mutations, and implications for genetic counseling. Fertil Steril 74:1164–1174CrossRefPubMed Daudin M, Bieth E, Bujan L et al (2000) Congenital bilateral absence of the vas deferens: clinical characteristics, biological parameters, cystic fibrosis transmembrane conductance regulator gene mutations, and implications for genetic counseling. Fertil Steril 74:1164–1174CrossRefPubMed
11.
go back to reference Bellanné-Chantelot C, Clauin S, Chauveau D et al (2005) Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. Diabetes 54:3126–3132CrossRefPubMed Bellanné-Chantelot C, Clauin S, Chauveau D et al (2005) Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. Diabetes 54:3126–3132CrossRefPubMed
12.
go back to reference Faguer S, Chassaing N, Bandin F et al (2014) The HNF1B score is a simple tool to select patients for HNF1B gene analysis. Kidney Int 86:1007–1015CrossRefPubMed Faguer S, Chassaing N, Bandin F et al (2014) The HNF1B score is a simple tool to select patients for HNF1B gene analysis. Kidney Int 86:1007–1015CrossRefPubMed
13.
go back to reference Ravine D, Gibson RN, Walker RG et al (1994) Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 343:824–827CrossRefPubMed Ravine D, Gibson RN, Walker RG et al (1994) Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 343:824–827CrossRefPubMed
14.
go back to reference Faguer S, Decramer S, Chassaing N et al (2011) Diagnosis, management, and prognosis of HNF1B nephropathy in adulthood. Kidney Int 80:768–776CrossRefPubMed Faguer S, Decramer S, Chassaing N et al (2011) Diagnosis, management, and prognosis of HNF1B nephropathy in adulthood. Kidney Int 80:768–776CrossRefPubMed
15.
go back to reference Oram R, Edghill EL, Blackman J et al (2010) Mutations in the hepatocyte nuclear factor-1β (HNF1B) gene are common with combined uterine and renal malformations but are not found with isolated uterine malformations. Am J Obstet Gynecol 203(364):e1–e5 Oram R, Edghill EL, Blackman J et al (2010) Mutations in the hepatocyte nuclear factor-1β (HNF1B) gene are common with combined uterine and renal malformations but are not found with isolated uterine malformations. Am J Obstet Gynecol 203(364):e1–e5
16.
go back to reference Bellanné-Chantelot C, Chauveau D, Gautier J-F et al (2004) Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations. Ann Intern Med 140:510–517CrossRefPubMed Bellanné-Chantelot C, Chauveau D, Gautier J-F et al (2004) Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations. Ann Intern Med 140:510–517CrossRefPubMed
17.
go back to reference Jungwirth A, Giwercman A, Tournaye H et al (2012) European Association of Urology guidelines on Male Infertility: the 2012 update. Eur Urol 62:324–332CrossRefPubMed Jungwirth A, Giwercman A, Tournaye H et al (2012) European Association of Urology guidelines on Male Infertility: the 2012 update. Eur Urol 62:324–332CrossRefPubMed
18.
go back to reference Nistal M, González-Peramato P, Sousa G et al (2010) Cystic dysplasia of the epididymis: a disorder of mesonephric differentiation associated with renal maldevelopment. Virchows Arch 456:695–702CrossRefPubMed Nistal M, González-Peramato P, Sousa G et al (2010) Cystic dysplasia of the epididymis: a disorder of mesonephric differentiation associated with renal maldevelopment. Virchows Arch 456:695–702CrossRefPubMed
19.
go back to reference Decramer S, Parant O, Beaufils S et al (2007) Anomalies of the TCF2 gene are the main cause of fetal bilateral hyperechogenic kidneys. J Am Soc Nephrol 18:923–933CrossRefPubMed Decramer S, Parant O, Beaufils S et al (2007) Anomalies of the TCF2 gene are the main cause of fetal bilateral hyperechogenic kidneys. J Am Soc Nephrol 18:923–933CrossRefPubMed
21.
go back to reference Gao Z, Ruden DM, Lu X (2003) PKD2 cation channel is required for directional sperm movement and male fertility. Curr Biol 13:2175–2178CrossRefPubMed Gao Z, Ruden DM, Lu X (2003) PKD2 cation channel is required for directional sperm movement and male fertility. Curr Biol 13:2175–2178CrossRefPubMed
Metadata
Title
The spectrum of renal involvement in male patients with infertility related to excretory-system abnormalities: phenotypes, genotypes, and genetic counseling
Authors
Roger Mieusset
Isabelle Fauquet
Dominique Chauveau
Laetitia Monteil
Nicolas Chassaing
Myriam Daudin
Antoine Huart
François Isus
Cathy Prouheze
Patrick Calvas
Eric Bieth
Louis Bujan
Stanislas Faguer
Publication date
01-04-2017
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 2/2017
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-016-0286-5

Other articles of this Issue 2/2017

Journal of Nephrology 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine